Ardelyx reported $202.14M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Abbott USD 9.9B 1.7B Dec/2025
Amgen USD 50B 2.43B Dec/2025
Ardelyx USD 202.14M 27.07M Sep/2025
aTyr Pharma USD 398K 204K Sep/2025
Curis USD 29.43M 10.69M Jun/2024
Sanofi EUR 15.72B 150.06M Dec/2025
TG Therapeutics USD 245.34M 303K Sep/2025
United Therapeutics USD 100M 100M Jun/2024
Xoma USD 94.38M 7.82M Sep/2025